Pardes Biosciences Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Pardes Biosciences's estimated annual revenue is currently $7.1M per year.(i)
  • Pardes Biosciences's estimated revenue per employee is $126,000

Employee Data

  • Pardes Biosciences has 56 Employees.(i)
  • Pardes Biosciences grew their employee count by 30% last year.

Pardes Biosciences's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chairman and CEOReveal Email/Phone
3
VP, FinanceReveal Email/Phone
4
General Counsel and Corporate SecretaryReveal Email/Phone
5
Accounts Payable ManagerReveal Email/Phone
6
Senior QA ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$223.4M11165%$65MN/A
#2
$41.9M27218%N/AN/A
#3
$55.8M314-5%$102.6MN/A
#4
$3.4M32-24%$21.3MN/A
#5
$35.7M2370%$42.9MN/A
#6
$3.8M36-27%$35MN/A
#7
$0.9M11N/AN/AN/A
#8
$13.9M99-9%N/AN/A
#9
$18.2M1300%$96.4MN/A
#10
$6.2M51-25%$75.6MN/A
Add Company

What Is Pardes Biosciences?

Better chemistry committed to the world's biggest problems

keywords:N/A

N/A

Total Funding

56

Number of Employees

$7.1M

Revenue (est)

30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Pardes Biosciences News

2022-04-17 - Loss-Making Pardes Biosciences, Inc. (NASDAQ:PRDS) Expected To Breakeven In The Medium-Term

Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics...

2022-04-06 - Pardes Biosciences Inc.

Pardes Biosciences Inc is a clinical-stage biopharmaceutical company created for solving pandemic-sized problems, starting with COVID-19.

2022-03-22 - Pardes Biosciences Reports Full Year 2021 Financial Results ...

About Pardes Biosciences, Inc. Pardes Biosciences is a clinical-stage biopharmaceutical company created to help solve pandemic-sized problems,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.9M570%N/A
#2
$13.9M57-12%N/A
#3
$13.9M578%N/A
#4
$3.5M5727%N/A
#5
$12.5M5721%N/A